This site is intended for Healthcare professionals only.

Granules India gets USFDA nod for muscle pain tablets


Granules India gets USFDA nod for muscle pain tablets

NEW DELHI: Granules India has received approval from the US health regulator for generic Methocarbamol tablets in two strengths used for the treatment of muscle spasms and pain.

The USFDA has approved the abbreviated new drug application (ANDA) for Methocarbamol tablets in the strengths of 500 mg and 750 mg, Granules India said in a filing to the BSE.

The product is the generic version of Auxilium Pharmaceuticals LLC’s Robaxin tablets in the same strength The company intends to commercialise the product shortly, the filing said.

Shares of Granules India were trading at Rs 100.05 per scrip on BSE, down 0.30 percent from the previous close



Source: PTI
0 comment(s) on Granules India gets USFDA nod for muscle pain tablets

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted